BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22491493)

  • 1. Newborn screening for cystic fibrosis.
    Wagener JS; Zemanick ET; Sontag MK
    Curr Opin Pediatr; 2012 Jun; 24(3):329-35. PubMed ID: 22491493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.
    ; Borowitz D; Robinson KA; Rosenfeld M; Davis SD; Sabadosa KA; Spear SL; Michel SH; Parad RB; White TB; Farrell PM; Marshall BC; Accurso FJ
    J Pediatr; 2009 Dec; 155(6 Suppl):S73-93. PubMed ID: 19914445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Psychological Impact on Parents of Children who Receive an Inconclusive Diagnosis for Cystic Fibrosis following Newborn Screening: A Systematic Mini-Review.
    Loukou I; Moustaki M; Douros K
    Children (Basel); 2024 Jan; 11(1):. PubMed ID: 38255406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of primary care clinicians in detecting and managing cystic fibrosis: A commentary on Advancing Early Identification of Cystic Fibrosis through Newborn Screening.
    Hicks SD
    Curr Probl Pediatr Adolesc Health Care; 2024 Jun; 54(6):101638. PubMed ID: 38797571
    [No Abstract]   [Full Text] [Related]  

  • 5. The Changing Face of Cystic Fibrosis and Its Implications for Screening.
    Naehrlich L
    Int J Neonatal Screen; 2020 Sep; 6(3):54. PubMed ID: 33123635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening for cystic fibrosis.
    Castellani C; Massie J; Sontag M; Southern KW
    Lancet Respir Med; 2016 Aug; 4(8):653-661. PubMed ID: 27053341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test.
    Rock MJ; Mischler EH; Farrell PM; Bruns WT; Hassemer DJ; Laessig RH
    Pediatr Pulmonol; 1989; 6(1):42-8. PubMed ID: 2704582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis.
    Conti J; Sorio C; Melotti P
    Children (Basel); 2022 Dec; 10(1):. PubMed ID: 36670555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic Fibrosis.
    Dickinson KM; Collaco JM
    Pediatr Rev; 2021 Feb; 42(2):55-67. PubMed ID: 33526571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Invasive Biomarkers for Early Detection of Breast Cancer.
    Li J; Guan X; Fan Z; Ching LM; Li Y; Wang X; Cao WM; Liu DX
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis knowledge and practice among primary care physicians in southwest region, Saudi Arabia.
    Asseri AA
    J Family Med Prim Care; 2020 Mar; 9(3):1354-1361. PubMed ID: 32509615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of genomic screening: cross-sectional study of cystic fibrosis in 50,788 electronic health records.
    Sugunaraj JP; Brosius HM; Murray MF; Manickam K; Stamm JA; Carey DJ; Mirshahi UL
    NPJ Genom Med; 2019; 4():21. PubMed ID: 31508243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.
    Hoppe JE; Wagner BD; Sagel SD; Accurso FJ; Zemanick ET
    BMC Pulm Med; 2017 Dec; 17(1):188. PubMed ID: 29228933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening.
    Gelfond D; Heltshe SL; Skalland M; Heubi JE; Kloster M; Leung DH; Ramsey BW; Borowitz D;
    J Pediatr Gastroenterol Nutr; 2018 Apr; 66(4):657-663. PubMed ID: 29176494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring approaches to facilitate family communication of genetic risk information after cystic fibrosis population carrier screening.
    Gorrie A; Archibald AD; Ioannou L; Curnow L; McClaren B
    J Community Genet; 2018 Jan; 9(1):71-80. PubMed ID: 28971321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic Fibrosis: The Dawn of a New Therapeutic Era.
    Heltshe SL; Cogen J; Ramos KJ; Goss CH
    Am J Respir Crit Care Med; 2017 Apr; 195(8):979-984. PubMed ID: 27710011
    [No Abstract]   [Full Text] [Related]  

  • 17. Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California.
    Salinas DB; Sosnay PR; Azen C; Young S; Raraigh KS; Keens TG; Kharrazi M
    PLoS One; 2016; 11(5):e0155624. PubMed ID: 27214204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis.
    Ratjen F; Bell SC; Rowe SM; Goss CH; Quittner AL; Bush A
    Nat Rev Dis Primers; 2015 May; 1():15010. PubMed ID: 27189798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis newborn screening programs: implications of the CFTR variant spectrum in nonwhite patients.
    Pique L; Graham S; Pearl M; Kharrazi M; Schrijver I
    Genet Med; 2017 Jan; 19(1):36-44. PubMed ID: 27148940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-Generation Molecular Testing of Newborn Dried Blood Spots for Cystic Fibrosis.
    Lefterova MI; Shen P; Odegaard JI; Fung E; Chiang T; Peng G; Davis RW; Wang W; Kharrazi M; Schrijver I; Scharfe C
    J Mol Diagn; 2016 Mar; 18(2):267-82. PubMed ID: 26847993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.